N early all cases of cervical cancer are caused by oncogenic strains of human papillomavirus (HPV), and 70% of all cases are linked to types 16 and 18 alone (1) . Until the U.S. Food and Drug Administration approved the HPV vaccine for use among women and girls aged 11 to 26 years in 2006 (2) , the prevention of cervical cancer centered on regular Papanicolaou (Pap) testing to detect precancerous changes in cervical cells. Today, the HPV vaccine, which targets HPV types 16 and 18, provides an effective strategy for the primary prevention of cervical cancer (3) .
Lesbian and bisexual women are at risk for HPV and cervical cancer from both female and male sexual partners throughout their life course (4 -6) . Indeed, HPV can be transmitted by not only penile-vaginal sexual intercourse, in which most lesbians have engaged at some time in their lives (4), but also skin-to-skin or digital-genital contact with a sexual partner of any sex (6 -10) . In addition, the prevalence of genital HPV infection among women with only female sexual partners is similar to that of women who have sex with men (11) (12) (13) . However, despite their risk for HPV infection, lesbians have limited knowledge of female-to-female HPV transmission and its implications for cervical cancer risk and may not perceive prevention messages for HPV and cervical cancer as being relevant to them (14 -19) .
The Advisory Committee on Immunization Practices recommends that all U.S. girls and young women aged 11 to 26 years receive the HPV vaccine, regardless of sexual identity or sexual behavior (3) . Human papillomavirus vaccination may be especially critical for lesbians, who may be at greater risk for cervical cancer than heterosexual women. At this time, researchers cannot assess cervical cancer incidence by sexual orientation identity because U.S. cancer registries do not collect data on sexual orientation. Nonetheless, several studies have consistently shown that regular Pap testing, which is critical in preventing cervical cancer (20) , is lower among lesbians than their heterosexual counterparts (21) (22) (23) (24) (25) (26) (27) . In addition, lesbians may be at greater risk for cervical cancer than heterosexual women because of a higher prevalence of smoking (28) , which is a risk factor for cervical cancer (29), and obesity (30) , which has been linked to cervical cancer death (31), as well as a lower prevalence of health insurance (21, (32) (33) (34) (35) and access to health care (34, 36) .
Despite evidence that lesbians are susceptible to HPV infection and research suggesting that this underserved population may be at elevated risk for cervical cancer morbidity and mortality, no study has investigated the relationship between sexual orientation identity and HPV vaccination among women and girls. Only 1 study has assessed the predictors of HPV vaccination in a national nonprobability sample of predominately white lesbian and bisexual young adult women in the United States (37) . Thus, we examined sexual orientation identity disparities in awareness and initiation of the HPV vaccine using a national probability sample of adolescent and young adult U.S women. We hypothesized that lesbians had lower levels of awareness and initiation of the HPV vaccine than heterosexual women and girls and that bisexual and heterosexual women and girls had similar levels of awareness and initiation of the HPV vaccine.
METHODS

Study Participants
We analyzed data from the 2006 -2010 National Survey of Family Growth (NSFG), which used a stratified, 3-stage cluster sampling strategy to establish a national probability sample of 12 279 civilian noninstitutionalized U.S. women aged 15 to 44 years (38) . We restricted our analysis to women aged 15 
Measures
The 2 outcomes of interest were awareness and initiation of the HPV vaccine, and the primary predictor was sexual orientation identity. The 2006 -2010 NSFG assessed awareness by asking, "Before today, have you ever heard of the cervical cancer vaccine, HPV shot, or Gardasil [Merck] ?" The survey asked women and girls aged 15 to 25 years who reported having ever heard of the HPV vaccine, "Have you received the cervical cancer vaccine, also known as the HPV shot or Gardasil?" Possible responses for both questions included "yes," "no," or "don't know" (coded as missing). During the Audio Computer-Assisted Self-Interview (ACASI) portion of the survey, respondents were asked about their sexual orientation identity. Response options included "heterosexual or straight;" "bisexual;" and "homosexual, gay, or lesbian," as well as "something else" (in years 1 and 2 only), "don't know," or "refused," which were grouped into a single "not reported" category. The choice of covariates included in statistical models was informed by ecosocial theory, which emphasizes the embodiment of societal factors in the form of population health outcomes, including health inequities (39 -43) . Prehypothesized covariates, shown with their categorization in Table 1 , included sociodemographic factors and indicators of health care access and utilization.
Statistical Analysis
After generating descriptive statistics for all prehypothesized covariates by sexual orientation identity, we used multivariable logistic regression models, which included sociodemographic factors and indicators of health care access and utilization to obtain adjusted prevalence estimates (predictive margins) of awareness and initiation of the HPV vaccine among U.S. women and girls aged 15 to 25 years for each sexual orientation identity group. Predictive margins use the distribution of covariates in the study population to obtain standardized outcome estimates that can be compared across groups (44, 45) . The predictive margin for a given sexual orientation identity group represents the average predicted response if everyone in the study population had been a member of that group (44, 45) . The P values for the comparison of awareness and initiation of the HPV vaccine between a given sexual orientation identity group and heterosexual women and girls (reference group) were obtained from the underlying multivariable logistic regression models (44) . All analyses accounted for the complex survey design (stratification; clustering; and sampling, response, and coverage rates) using the svy commands in Stata, version 13 (StataCorp).
We determined that our sample was large enough on the basis of our estimation that 43 lesbians and 43 heterosexual women and girls would provide 80% power to detect expected differences in HPV vaccination, assuming prevalence estimates of 10% among lesbians and 34.5% (46) among heterosexual women and girls and a type I error of 0.05. No data were missing for awareness of the HPV vaccine; among women who had ever heard of the HPV vaccine, 6 (0.23%) were missing
EDITORS' NOTES Context
The human papillomavirus (HPV) vaccine is effective in reducing the incidence of HPV and cervical cancer and is recommended for all U.S. women and girls aged 11 to 26 years, regardless of sexual identity or behavior.
Contribution
In a national probability sample, lesbian women and girls, despite being at greater risk for cervical cancer morbidity and mortality, were significantly less likely to initiate HPV vaccination than their heterosexual counterparts.
Caution
Information was obtained by self-report.
Implication
Targeted efforts may be needed to increase receipt of the HPV vaccine among U.S. lesbian women and girls.
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Sexual Orientation Identity and Awareness and Initiation of the HPV Vaccine data on initiation. Missing data for age, race/ethnicity, religion in which the respondent was raised, relationship status, education level, household poverty level, employment status, and health insurance status were imputed by NSFG staff using the sequential regression imputation method (47) . The proportion of women and girls missing data on covariates that were not imputed by NSFG staff was small (≤0.3%).
This study was not determined to be human subject research by the Office of Human Research Administration at Harvard Longwood Medical Area (Boston, Massachusetts). Values are prevalence estimates presented as percentages and account for the complex survey design. Percentages may not sum to 100 due to rounding. † Includes women and girls who responded "something else," "don't know," or "refused" to the sexual orientation identity question. ‡ Refers to women and girls covered only by a single service plan or the Indian Health Service.
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Role of the Funding Source
This study was funded by the National Cancer Institute. The funding source played no role in the design or conduct of the analyses, the interpretation of the results, or the decision to submit the manuscript for publication.
RESULTS
Using 2006 -2010 NSFG data (the response rate for the entire sample for women aged 15 to 44 years was 77.7%; the response rate for women aged 15 to 19 years and 20 to 44 years was 77.4% and 77.7%, respectively), we estimated the distribution of sociodemographic factors and indicators of health care access and utilization by sexual orientation identity among U.S. adolescent and young adult women ( Table 1) . Among women and girls aged 15 to 25 years (n = 3253), lesbian respondents tended to be older and have been raised in a nonreligious household relative to their heterosexual counterparts. Although lesbians were more likely to work in the labor force, have a high school degree or higher, and have a household income at or above 200% of the federal poverty level than heterosexual women and girls, they were more likely to be uninsured or underinsured and were considerably less likely to have received contraception and sexually transmitted infection (STI) services in the past year.
Bisexual women and girls were more likely to be white, have been raised in a nonreligious household, and be living below 100% of the federal poverty level than their heterosexual counterparts; they were also less likely to be working in the labor force and have a bachelor's degree or higher. In addition, bisexual women and girls were more likely to be enrolled in a public health insurance plan and have received contraception and STI services in the past year than heterosexual women and girls. Further, respondents in the "not reported" sexual orientation identity group were more likely to be Latina immigrants, have less than a high school diploma, be living below 100% of the federal poverty level, be uninsured or underinsured, and have been raised in a Catholic household than heterosexual women and girls ( Table 1) .
Among U.S. women and girls aged 15 to 25 years (n = 3253), 2698 (84.4%) reported having ever heard of the HPV vaccine; of these, 28.5% had initiated vaccination at some time in their lives ( Table 2) . Table 2 presents the adjusted prevalence of awareness and initiation of the HPV vaccine by sexual orientation identity, which we obtained using multivariable logistic regression models that included sociodemographic factors and indicators of health care access and utilization. Appendix Tables 1 and 2 (available at www.annals.org) present results from these regression models. The adjusted prevalence of awareness of the HPV vaccine was similar among heterosexual, bisexual, and lesbian respondents, as shown by estimates' overlapping 95% CIs ( Table 2) . After adjustment for covariates, the proportion of women and girls aged 15 to 25 years who had heard of the HPV vaccine was significantly lower (P = 0.004) among respondents in the "not reported" sexual orientation identity group (odds ratio, 68.4% [CI, 56.6% to 80.2%]), who tended to be Latina immigrants with lower socioeconomic positions, than those who identified as heterosexual (odds ratio, 84.4% [CI, 81.6% to 87.2%]; P = 0.004) ( Table 2) .
Among women and girls who had heard of the HPV vaccine, 8.5% (95% CI, 0.0% to 17.2%) of lesbians had initiated vaccination compared with 28.4% (CI, 25.2% to 31.6%; P = 0.007) of their heterosexual counterparts, after adjustment for sociodemographic factors and indicators of health care access and utilization ( Table 2) . The adjusted prevalence of initiation of the HPV vaccine was similar among women and girls in the heterosexual, bisexual, and "not reported" groups, as shown by estimates' overlapping CIs ( Table 2) .
DISCUSSION
To our knowledge, this is the first study to assess the relationship between sexual orientation identity Prevalence estimates (percentages) specific to sexual orientation identity are predictive margins of the probability of awareness and initiation of the HPV vaccine standardized for the distribution of age, race/ethnicity, country of birth, religion in which the respondent was raised, relationship status, education level, household poverty level, employment status, health insurance status, receipt of contraception in the past year, and receipt of sexually transmitted infection services in the past year in the study population. All prevalence estimates and 95% CIs account for the complex survey design. P values were obtained from multivariable logistic regression models. † Applies only to those who reported having ever heard of the HPV vaccine. ‡ Includes women and girls who responded "something else," "don't know," or "refused" to the sexual orientation identity question.
ORIGINAL RESEARCH Sexual Orientation Identity and Awareness and Initiation of the HPV Vaccine
and awareness and initiation of the HPV vaccine in a national probability sample of U.S. women and girls. A total of 84.4% of U.S. women and girls aged 15 to 25 years reported having heard of the HPV vaccine; of these, 28.5% had initiated HPV vaccination at some time in their lives. The adjusted prevalence of awareness of the HPV vaccine was similar among heterosexual, bisexual, and lesbian respondents. After adjustment for sociodemographic factors and indicators of health care access and utilization, we found a significantly lower adjusted prevalence of having ever heard of the HPV vaccine among respondents in the "not reported" sexual orientation identity group, which consisted primarily of Latina immigrants with lower socioeconomic positions, than heterosexual respondents. Among women and girls who had heard of the HPV vaccine, the adjusted prevalence of HPV vaccine initiation was significantly lower among lesbians than their heterosexual counterparts. The proportion of women and girls who had initiated vaccination was similar among the heterosexual, bisexual, and "not reported" groups, after adjustment for covariates. Similar to our findings, validation research on the measure of sexual orientation identity used in the NSFG showed that Spanish-speaking women and women of lower educational attainment were more likely to respond "don't know" or "refused" than women with other social and economic backgrounds, possibly because of issues with the translation or comprehension of the response categories (48) . Therefore, women in the "not reported" sexual orientation identity group may be less likely than heterosexual women to have ever heard of the HPV vaccine because of the lack of available information written in their language and at their reading level and fewer opportunities for communication with health care providers (due to a higher proportion of uninsured and underinsured women in this group).
As suggested by previous research, adolescent and young adult lesbians may be less likely to have initiated HPV vaccination than their heterosexual counterparts because of the knowledge, attitudes, and beliefs related to sexual orientation and HPV risk held by young women, health care providers, and parents and caregivers. First, adolescents and young adults who identified as lesbians may not know or believe that the HPV vaccine is relevant to them. Indeed, previous research shows that, although lesbians are at risk for acquiring HPV and other STIs from female and male sexual partners throughout their life course (6, 18, 49 -51), they may not perceive themselves as being at risk for HPV (15, 17) or cervical cancer (19) . These beliefs stem from the widespread misconception among lesbians (14, 15, 17) and their health care providers (18, 52, 53) that HPV cannot be transmitted through female-tofemale sexual contact and that lesbians are not at risk for HPV from past sexual activity with men, in which most lesbians have engaged at some time in their lives (4). These misconceptions are fueled by lesbians' marginalization and invisibility in sexual health discourse and promotion efforts, which center on penile-vaginal sexual intercourse (15, 18, 19) .
Second, as a result of misinformation about HPV and cervical cancer risk among lesbians and limited training in women's sexuality and sexual health (18, (52) (53) (54) , health care providers may not offer prevention services for cervical cancer, including Pap tests and possibly the HPV vaccine, to their lesbian patients (14, 18) . In fact, clinicians may even discourage lesbians from obtaining such preventive care (55) . Underscoring health care providers' influence on young women's receipt of the HPV vaccine, several studies found that discussing the vaccine with a clinician was positively associated with vaccine initiation among young U.S. women (56 -58), including lesbian and bisexual women aged 18 to 26 years (37) . Moreover, lesbians may be reluctant to obtain health services, such as HPV vaccination, because of fears and previous experiences of heterosexism in the health care system, including heteronormative assumptions by health care providers and negative treatment after sexual orientation disclosure (9, 52, 59, 60) .
Third, research shows that parents and caregivers play an important role in shaping the HPV vaccination attitudes and behaviors of adolescent and young adult women (61) (62) (63) . For example, in a cross-sectional study of 972 predominately white female undergraduate students aged 18 to 25 years, Roberts and colleagues (62) found that mothers' approval of HPV vaccination was positively associated with vaccine initiation in this population. Additional research is needed to understand the extent to which parent-and caregiver-related factors, such as parents' perceptions of their daughter's HPV risk based on her sexual identity or the sex of her sexual partners, may contribute to sexual orientation disparities in HPV vaccination among adolescent and young adult U.S. women.
In contrast, initiation of the HPV vaccine may not differ between bisexual and heterosexual women because, as other studies show, bisexual women are more likely to perceive themselves as being at risk for STIs than lesbians (64). Indeed, although most lesbians have engaged in sexual activity with men at some time in their lives (4), bisexual women are more likely than lesbians to have a recent or current male sexual partner and to have been in a serious relationship with a man (65) . Thus, heteronormative messages about safer sex and STI risk and prevention may resonate more with bisexual than lesbian women and girls (15) . Likewise, because bisexual women are more likely to be in a current relationship with a man than lesbians (65), health care providers may be more likely to assume that their HPV risk is similar to that of heterosexual women with current male sexual partners.
Our study has several notable strengths, including the use of a large national probability sample with very few missing data that include an extensively validated measure of sexual orientation identity obtained by ACASI, which promotes privacy and helps decrease misclassification (such as declining to respond as opposed to answering "homosexual, gay, or lesbian" beSexual Orientation Identity and Awareness and Initiation of the HPV Vaccine ORIGINAL RESEARCH cause of perceived interviewer bias) (48) . Nonetheless, our findings should be interpreted in light of some limitations. First, we used self-reported, cross-sectional data, which precludes causal inference. Second, the 2006 -2010 NSFG measured only awareness of the HPV vaccine; thus, we could not assess sexual orientation identity disparities in participants' knowledge of specific aspects of the HPV vaccine or the type, quality, and relevance of the information they received about the vaccine. Third, the only indicator of HPV vaccination included in the 2006 -2010 NSFG was initiation of the vaccine. As a result, we had no information about whether participants completed the 3-dose series, which is of greater relevance to the prevention of HPV and cervical cancer than initiation.
Fourth, the 2006 -2010 NSFG did not collect data on having a usual source of preventive health care, which may partially account for observed sexual orientation identity disparities in initiation of the HPV vaccine. Fifth, the data used in this study were collected between 2006 and 2010. Since then, there have been important societal changes that could influence the relationship between sexual orientation identity and initiation of the HPV vaccine, including the passage of the Patient Protection and Affordable Care Act and the legalization of same-sex marriage in most U.S. states. Thus, our findings may not be generalizable to periods after 2006 to 2010. Last, the number of lesbians in this study was small; future studies should investigate sexual orientation identity disparities in awareness and initiation of the HPV vaccine among adolescent and young adult U.S. women using samples that include larger numbers of lesbians to obtain more precise national estimates for this population.
Future quantitative and qualitative research is needed to identify the mechanisms that drive sexual orientation identity disparities in awareness and initiation of the HPV vaccine among U.S. women and girls. In the meantime, government agencies and communitybased organizations can develop education materials about the HPV vaccine that are written in Spanish and at a reading level that is accessible to the "not reported" sexual orientation identity group, which was less likely than the heterosexual group to have heard of the HPV vaccine and primarily consisted of Latina immigrant with low socioeconomic positions.
Moreover, health care facilities and communitybased organizations can implement programs that provide young lesbians, health care providers, and parents and caregivers with complete and accurate information about female-to-female HPV transmission, risk for HPV and cervical cancer among lesbians from female and male sexual partners throughout the life course, and the need for HPV vaccination among adolescent and young adult women of all sexual orientations (15, 52) . Medical and nursing schools should incorporate information on women's sexuality and sexual health, including risk for and prevention of HPV and cervical cancer among lesbians, in their curricula (52) (53) (54) . In addition, community health centers, hospitals, and schools can offer opt-out programs for HPV vaccination tailored to the specific sexual experiences and health care needs of adolescent and young adult lesbians (15) . These initiatives may help ensure that young lesbians, an underserved population that is at risk for HPV, do not face an undue burden of cervical cancer in adulthood because of barriers to HPV vaccination in earlier years (66 FPL = federal poverty level; HPV = human papillomavirus; STI = sexually transmitted infection. * Analyses were restricted to women and girls aged 15-25 y who participated in years 2-4 of the survey (n = 3253). Values are odds ratios (95% CIs). All odds ratios account for the complex survey design. † Adjusted for age only. ‡ Adjusted for age and other sociodemographic factors. § Also includes health care indicators. ͉͉ Includes women and girls who responded "something else," "don't know," or "refused" to the sexual orientation identity question. ¶ Odds ratios with 95% CIs that exclude 1. ** Refers to women and girls covered only by a single service plan or the Indian Health Service.
